Stocks Bayer AG


  • Chinese President Xi Jinping (L) and German Chancellor Angela Merkel address a press conference after a political and economic agreements signing ceremony at the chanellery in Berlin.

    "Smiling from a safe distance" is how German media described China's President Xi Jinping during his press conference last Friday.

  • European stock markets trimmed last week's gains to close lower on Monday, off the back of weak Chinese data and tensions in Ukraine.

  • Europe shares close flat; Bayer up 2.7%

    European stocks closed flat on Friday, boosted by economic data from the U.S.

  • German pharmaceutical group Bayer offered to buy Norway's Algeta for $2.4 billion, Algeta said on Tuesday.

  • Contraceptive pills.

    A majority of women are unaware birth control is available for free from health insurance plans under Obamacare, although that right faces court challenges.

  • We could be witnessing the beginning of a merger wave in biotech, Jim Cramer said Tuesday.

  • amgen-200.jpg

    Amgen has struck a $10 billion-plus deal to buy Onyx Pharmaceuticals, ending a two-month-long auction for the cancer drugmaker.

  •  Bayer CEO: Environment becoming more challenging

    Marijn Dekkers, CEO of drug and chemicals company Bayer, tells CNBC that falling earnings in the material sciences division may make it harder to achieve its earnings goals for the year.

  • China is preventing a GlaxoSmithKline executive from leaving the country as police accuse the British drugmaker of bribing officials and doctors, the drugmaker says.

  • A federal judge in Kansas City, Kansas, ordered Dow Chemical Co on Wednesday to pay $1.2 billion in a price-fixing case involving chemicals used to make foam products in cars.

  • European shares closed higher on Monday after Italy's new Prime Minister announced his reform plans in his maiden speech to parliament.

  • Germany's Bayer has agreed to buy U.S. contraceptive devices maker Conceptus for $1.1 billion, aiming to underpin its position as the world's largest women's healthcare provider.

  • Bayer CEO: Agriculture Will Drive Profits

    Marijn Dekkers, CEO of Bayer, says the positive outlook for 2013 is driven by strong projected strong growth in Healthcare and Crop Sciences and explains how the company is heavily investing in its growth.

  • Stung by a landmark patent defeat, Western drugmakers will be wary about launching new products in India, but they cannot afford to quit a country with a market potential as large as India's.

  • Bayer CEO: Confident of Meeting Tough Targets

    Marijn Dekkers, CEO of Bayer, tells CNBC why the company's development of new drugs make him confident of reaching targets set of 2.5 billion euros in drug sales.

  • agricultural_biotech_200.jpg

    Syngenta, the world's largest agrochemicals company, said it was confident ahead of the upcoming planting season and will hike its dividend 19 percent after it posted a full-year net profit that beat expectations.

  • Busch: This Global Game of Chicken Hurts Markets

    Weak GDP data for the U.K. wasn't enough to stop European shares rising on Friday as Germany's DAX Index reached a level not seen since January 2008 after business climate data was released.

  • Bayer's Dekkers On  Innovation vs. Affordable Drugs

    Marijn Dekkers, CEO of Bayer, talks to CNBC about the outlook for the pharmaceutical industry

  • pills.jpg

    The big U.S. and European drug companies are dealing with their own 'cliff' as blockbuster drugs lose their patent protection. But they are turning back to research and development to fill the gap.

  • Bayer Has Promising Product Pipeline: CEO

    Marijn Dekkers, CEO of Bayer, explains to CNBC that while Bayer has felt increased pressure on drug pricing from governments, its success in research and development has the company positioned for success.